share_log

Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dmitry Genkin(13.0%),CLS Therapeutics Ltd.(9.6%), etc.

XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | SC 13D/A:超過5%持股股東披露文件(修正)-Dmitry Genkin(13.0%),CLS Therapeutics Ltd.(9.6%)等

美股sec公告 ·  2023/09/18 12:21
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息